About Allorion Therapeutics
Developing novel small molecule drugs against cancer and autoimmune diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Natick, United States
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
alloriontx.com
Domain Registered Date
Oct 28, 2019
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $50,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Series-A announced
- Milestone
X account created (@AllorionT)
21 followers
- Milestone
Website domain registered
alloriontx.com
Investors & Backers
3SBio Inc.
Elikon Venture
FirstLight Capital
IDG Capital
INCE Capital
LongRiver Investments
Med-Fine Capital
Octagon Capital Advisors
Qiming Venture Partners
TF Capital
Funding History
Series-B+
· Mar 10, 2023
$50,000,000 fundraisingfox.com
Series-A
· Nov 24, 2021
Undisclosed Source
Founders & Leadership
Qiang Ding
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026